Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flexible and scalable inference of spatially varying correlation in spatial transcriptomics with spCorr.

Genome research·2026
Same author

Single-cell map of the healthy human immune system across the lifespan reveals unique infant immune signatures.

Nature communications·2026
Same author

3D multi-omics tumour atlases: from technology to biology and clinical translation.

Nature reviews. Cancer·2026
Same author

HIRA-mediated H3.3 deposition preserves hepatocyte cell identity during liver aging.

Research square·2026
Same author

p21-senescent cells drive pancreatic islet dysfunction through targetable paracrine signaling in type 2 diabetes.

JCI insight·2026
Same author

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Nature cancer·2026
Same journal

Complex Indel Detection: A Simulation-Based Framework and Parsing with FreeBayes.

bioRxiv : the preprint server for biology·2026
Same journal

Emulating the gingival-tooth interface during bacterial, fungal, and viral infection in a microphysiological model of the human oral cavity.

bioRxiv : the preprint server for biology·2026
Same journal

Local SNP-explained methylation variation reveals genetically anchored and exposure-associated methylation architecture in the human brain.

bioRxiv : the preprint server for biology·2026
Same journal

Perinatal Semaglutide Treatment Improves Maternal Health and Mitigates Offspring Metabolic Dysfunction in a Mouse Model of Maternal Obesity.

bioRxiv : the preprint server for biology·2026
Same journal

Pervasive cryptic selection in the human noncoding genome.

bioRxiv : the preprint server for biology·2026
Same journal

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.

bioRxiv : the preprint server for biology·2026
See all related articles
  1. Home
  2. Distinct Senescent Β-cell Senotypes Differentially Drive Islet Aging And Dysfunction.
  1. Home
  2. Distinct Senescent Β-cell Senotypes Differentially Drive Islet Aging And Dysfunction.

Related Experiment Video

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
08:41

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

Published on: June 23, 2023

Distinct senescent β-cell senotypes differentially drive islet aging and dysfunction.

Kanako Iwasaki, Hui Pan, Jonathan Dreyfuss

    Biorxiv : the Preprint Server for Biology
    |June 5, 2026

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    Biological aging impairs glucose handling and increases type 2 diabetes risk. This study reveals two distinct pancreatic senescent cell types, one maladaptive and one adaptive, offering new therapeutic targets for diabetes.

    Related Experiment Videos

    Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
    08:41

    Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters

    Published on: June 23, 2023

    Area of Science:

    • Endocrinology
    • Gerontology
    • Cell Biology

    Background:

    • Biological aging affects glucose metabolism and is a key risk factor for type 2 diabetes (T2D).
    • Cellular senescence in the human endocrine pancreas and its role in aging are not well understood at the single-cell level.
    • Senolytic therapies show promise, but heterogeneity of senescent cells requires further investigation.

    Purpose of the Study:

    • To investigate the heterogeneity and functional roles of senescent cells in the aging human pancreas at a single-cell resolution.
    • To identify distinct subpopulations of senescent cells (SnCs) and their specific characteristics.
    • To provide a framework for developing targeted senescence therapies for T2D.

    Main Methods:

    • Single-cell-resolved spatial proteomics and transcriptomics on intact human pancreas (26 donors, ages 20-80).
  • Multiplexed single-cell RNA sequencing and functional assays on dispersed human islets (14 donors, ages 34-69).
  • Identification and characterization of senescent cell subpopulations based on gene expression (CDKN1A, CDKN2A).
  • Main Results:

    • Two distinct senescent cell subpopulations (SnCs) were identified: CDKN1A⁺ and CDKN2A⁺.
    • CDKN1A⁺ SnCs showed loss of beta-cell identity, reduced insulin secretion, and a pro-inflammatory senescence-associated secretory phenotype (SASP), correlating with increased islet immune infiltration.
    • CDKN2A⁺ SnCs maintained transcriptional identity and function with lower inflammatory signaling.

    Conclusions:

    • Human pancreatic senescence is heterogeneous, with distinct senotypes.
    • An adaptive (CDKN2A⁺) and a maladaptive (CDKN1A⁺) senescence program exists in the pancreas.
    • These findings offer a mechanism-guided approach for developing senescence-targeted therapies for T2D.